Menu
Alkermes is the first drugmaker to announce it will leave Second Sight Solutions’ 340B ESP contract pharmacy clearinghouse to switch to drug industry vendor Kalderos’ new Truzo platform.

Alkermes 1st to Shift from 340B ESP to Kalderos’ Truzo Contract Pharmacy Platform; Providers Pan Transition Deadline

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Covered entities purchasing 340B-priced Alkermes products will have to submit claims data for the first time and do so via [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Bluesight

HRSA Clarifies 340B Rebate Pilot Won’t Disqualify Referral Scripts After Beacon Definition Raises Questions

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live